Le site du DES d'oncologie de Toulouse


Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Hématologie - Publié le 23/06/2019 par Gauthier Glemarec

Survivors of Hodgkin’s lymphoma are at increased risk for treatment-related subsequent malignant neoplasms. The effect of less toxic treatments, introduced in the late 1980s, on the long-term risk of a second cancer remains unknown.

Source : NEJM 12/2015